Vaccine Overview
Measles & Rubella Vaccine (Live) I.P.
The Measles & Rubella (MR) Vaccine (Live) I.P. is a combination vaccine used to protect against two highly contagious viral diseases—measles and rubella. Measles can lead to severe complications such as pneumonia, brain swelling, and even death, while rubella is especially dangerous during pregnancy, potentially causing birth defects. The vaccine contains live, weakened viruses that help the body build long-lasting immunity. It is typically administered to infants at 9 months and again at 15–18 months, with catch-up doses for older children and adolescents if needed. It is not recommended during pregnancy and is given via a 0.5 ml subcutaneous injection.
Drug Class: Viral Vaccines
Indication: For active immunization against Measles and Rubella in infants, children, Adolescents and young adults at risk
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
First dose at 9–12 months, second dose at 15–18 months
Administration
Route: Subcutaneous Injection
Site: Injected thorugh upper arm or thigh
Disease
Measles, Rubella
Manufacturer
Serum Intitute Of India
Age
- 9-18 months
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025